| Untreated NSCLC |
C3 |
Adenocarcinoma |
77 |
F |
|
| C4 |
Adenocarcinoma |
83 |
M |
| C5 |
Adenocarcinoma |
75 |
M |
| C6 |
Adenocarcinoma |
65 |
M |
| C7 |
Adenocarcinoma |
58 |
M |
| C8 |
Adenocarcinoma |
78 |
M |
| Treated NSCLC |
D1 |
Adenocarcinoma |
69 |
M |
Carboplatin, Taxotere, Pemetrexed |
| D2 |
Adenocarcinoma |
65 |
F |
Bevacizumab, Cisplatin, Navelbine, Carboplatin, Taxotere, Pemetrexed |
| D3 |
Adenocarcinoma |
77 |
M |
Cisplatin, 5-Fluorouracil |
| D4 |
Adenocarcinoma |
63 |
F |
Carboplatin, Pemetrexed |
| D5 |
Adenocarcinoma |
60 |
F |
Cisplatin, Pemetrexed |
| Untreated SCLC |
A1 |
Small cell carcinoma |
68 |
M |
|
| A2 |
Small cell carcinoma |
80 |
M |
| A5 |
Small cell carcinoma |
72 |
M |
| A7 |
Small cell carcinoma |
70 |
F |
| A8 |
Small cell carcinoma |
81 |
M |
| Treated SCLC |
B1 |
Small cell carcinoma |
62 |
F |
Carboplatin, Etoposide |
| B2 |
Small cell carcinoma |
70 |
M |
Carboplatin, Etoposide, Sunitinib |
| B3 |
Small cell carcinoma |
61 |
M |
Cisplatin, Etoposide, Carboplatin, Topotecan |
| B4 |
Small cell carcinoma |
69 |
M |
Cisplatin, Vinorelbine |
| Healthy Control |
LS8812673 |
|
24 |
F |
|
| LS5547864 |
27 |
F |
| LS5541008 |
26 |
F |
| LS2370663 |
27 |
F |
| LS2370341 |
25 |
F |
| LS2360497 |
29 |
M |
| LS5541302 |
28 |
M |
| LS8809463 |
26 |
M |
| LS8811933 |
28 |
M |
| LS8819505 |
38 |
M |
